Corteva (CTVA) Set to Announce Earnings on Wednesday

Corteva (NYSE:CTVA) is expected to post its Q3 2026 results after the market closes on Wednesday, November 11th. Analysts expect Corteva to post earnings of $0.0181 per share and revenue of $1.77 billion for the quarter. Individuals may review the information on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 12, 2026 at 9:00 AM ET.

Corteva Stock Down 0.0%

Shares of NYSE CTVA opened at $11.90 on Monday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm has a market cap of $7.94 billion, a PE ratio of 7.88, a P/E/G ratio of 1.66 and a beta of 0.58. The company’s fifty day simple moving average is $44.82 and its 200 day simple moving average is $71.09. Corteva has a 12-month low of $11.24 and a 12-month high of $90.97.

Corteva Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 1.7%. This is a decrease from Corteva’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Tuesday, December 1st. Corteva’s payout ratio is presently 47.68%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. UBS Group dropped their price objective on shares of Corteva to $15.00 and set a “neutral” rating on the stock in a report on Monday, October 12th. The Goldman Sachs Group restated a “buy” rating and issued a $20.00 target price on shares of Corteva in a research note on Thursday, October 8th. Citigroup boosted their target price on Corteva from $86.00 to $91.00 and gave the company a “neutral” rating in a research report on Thursday, September 17th. New Street Research set a $17.00 target price on Corteva in a research report on Monday, October 5th. Finally, BMO Capital Markets set a $15.00 price target on Corteva in a research note on Friday, October 2nd. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $60.59.

Corteva Company Profile

Corteva, Inc is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases.

Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Corteva became an independent, publicly traded company in 2019 following the separation of DowDuPont.